BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 34583104)

  • 1. Clinical application of serological Alzheimer's disease diagnosis using a highly sensitive biosensor with hydrogel-enhanced dielectrophoretic force.
    Kim HJ; Choi W; San Lee J; Choi J; Choi N; Hwang KS
    Biosens Bioelectron; 2022 Jan; 195():113668. PubMed ID: 34583104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma-based diagnostic and screening platform using a combination of biosensing signals in Alzheimer's disease.
    Kim HJ; Kim H; Park D; Yoon DS; San Lee J; Hwang KS
    Biosens Bioelectron; 2023 Jun; 230():115246. PubMed ID: 37003061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for cerebral amyloid angiopathy based on serological biomarkers analysis using a dielectrophoretic force-driven biosensor platform.
    Kim HJ; Park D; Yun G; Kim H; Kim HG; Lee KM; Hong IK; Park KC; Lee JS; Hwang KS
    Lab Chip; 2021 Nov; 21(23):4557-4565. PubMed ID: 34724019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbiosensor for Alzheimer's disease diagnostics: detection of amyloid beta biomarkers.
    Prabhulkar S; Piatyszek R; Cirrito JR; Wu ZZ; Li CZ
    J Neurochem; 2012 Jul; 122(2):374-81. PubMed ID: 22372824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dielectrophoresis-based filtration effect and detection of amyloid beta in plasma for Alzheimer's disease diagnosis.
    Kim HJ; Park D; Baek SY; Yang SH; Kim Y; Lim SM; Kim J; Hwang KS
    Biosens Bioelectron; 2019 Mar; 128():166-175. PubMed ID: 30660932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chitosan mediated layer-by-layer assembly based graphene oxide decorated surface plasmon resonance biosensor for highly sensitive detection of β-amyloid.
    Nangare S; Patil P
    Int J Biol Macromol; 2022 Aug; 214():568-582. PubMed ID: 35752342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New assay for old markers-plasma beta amyloid of mild cognitive impairment and Alzheimer's disease.
    Chiu MJ; Yang SY; Chen TF; Chieh JJ; Huang TZ; Yip PK; Yang HC; Cheng TW; Chen YF; Hua MS; Horng HE
    Curr Alzheimer Res; 2012 Dec; 9(10):1142-8. PubMed ID: 22950866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A digital enzyme-linked immunosorbent assay for ultrasensitive measurement of amyloid-β 1-42 peptide in human plasma with utility for studies of Alzheimer's disease therapeutics.
    Song L; Lachno DR; Hanlon D; Shepro A; Jeromin A; Gemani D; Talbot JA; Racke MM; Dage JL; Dean RA
    Alzheimers Res Ther; 2016 Dec; 8(1):58. PubMed ID: 27978855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isobaric Quantification of Cerebrospinal Fluid Amyloid-β Peptides in Alzheimer's Disease: C-Terminal Truncation Relates to Early Measures of Neurodegeneration.
    Rogeberg M; Almdahl IS; Wettergreen M; Nilsson LN; Fladby T
    J Proteome Res; 2015 Nov; 14(11):4834-43. PubMed ID: 26452689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF amyloid-beta-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia.
    Bibl M; Mollenhauer B; Esselmann H; Lewczuk P; Klafki HW; Sparbier K; Smirnov A; Cepek L; Trenkwalder C; Rüther E; Kornhuber J; Otto M; Wiltfang J
    Brain; 2006 May; 129(Pt 5):1177-87. PubMed ID: 16600985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adsorptive filtration systems for effective removal of blood amyloid β: a potential therapy for Alzheimer's disease.
    Kitaguchi N; Kawaguchi K; Yamazaki K; Kawachi H; Sakata M; Kaneko M; Kato M; Sakai K; Ohashi N; Hasegawa M; Hiki Y; Yuzawa Y
    J Artif Organs; 2018 Jun; 21(2):220-229. PubMed ID: 29230564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined determination of copper ions and β-amyloid peptide by a single ratiometric electrochemical biosensor.
    Yu Y; Wang P; Zhu X; Peng Q; Zhou Y; Yin T; Liang Y; Yin X
    Analyst; 2017 Dec; 143(1):323-331. PubMed ID: 29192910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer's disease.
    Chatterjee P; Pedrini S; Stoops E; Goozee K; Villemagne VL; Asih PR; Verberk IMW; Dave P; Taddei K; Sohrabi HR; Zetterberg H; Blennow K; Teunissen CE; Vanderstichele HM; Martins RN
    Transl Psychiatry; 2021 Jan; 11(1):27. PubMed ID: 33431793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasensitive probeless capacitive biosensor for amyloid beta (Aβ
    Sharma PK; Kim ES; Mishra S; Ganbold E; Seong RS; Kim YM; Jahng GH; Rhee HY; Han HS; Kim DH; Kim ST; Kim NY
    Biosens Bioelectron; 2022 Sep; 212():114365. PubMed ID: 35671696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decoding the synaptic dysfunction of bioactive human AD brain soluble Aβ to inspire novel therapeutic avenues for Alzheimer's disease.
    Li S; Jin M; Liu L; Dang Y; Ostaszewski BL; Selkoe DJ
    Acta Neuropathol Commun; 2018 Nov; 6(1):121. PubMed ID: 30409172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Relationship Between Plasma Aβ Levels, Cognitive Function and Brain Volumetrics: Sydney Memory and Ageing Study.
    Poljak A; Crawford JD; Smythe GA; Brodaty H; Slavin MJ; Kochan NA; Trollor JN; Wen W; Mather KA; Assareh AA; Ng PC; Sachdev PS
    Curr Alzheimer Res; 2016; 13(3):243-55. PubMed ID: 26679856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma amyloid levels within the Alzheimer's process and correlations with central biomarkers.
    Hanon O; Vidal JS; Lehmann S; Bombois S; Allinquant B; Tréluyer JM; Gelé P; Delmaire C; Blanc F; Mangin JF; Buée L; Touchon J; Hugon J; Vellas B; Galbrun E; Benetos A; Berrut G; Paillaud E; Wallon D; Castelnovo G; Volpe-Gillot L; Paccalin M; Robert PH; Godefroy O; Dantoine T; Camus V; Belmin J; Vandel P; Novella JL; Duron E; Rigaud AS; Schraen-Maschke S; Gabelle A;
    Alzheimers Dement; 2018 Jul; 14(7):858-868. PubMed ID: 29458036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Microchip Electrophoresis," with Respect to "Profiling of Aβ Peptides in the Cerebrospinal Fluid of Patients with Alzheimer's Disease".
    Mohamadi MR; Verpillot R; Taverna M; Otto M; Viovy JL
    Methods Mol Biol; 2019; 1855():327-340. PubMed ID: 30426429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct deposition of amyloid-β species in brains with Alzheimer's disease pathology visualized with MALDI imaging mass spectrometry.
    Kakuda N; Miyasaka T; Iwasaki N; Nirasawa T; Wada-Kakuda S; Takahashi-Fujigasaki J; Murayama S; Ihara Y; Ikegawa M
    Acta Neuropathol Commun; 2017 Oct; 5(1):73. PubMed ID: 29037261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of plasma amyloid-β levels in Alzheimer's disease.
    Song F; Poljak A; Valenzuela M; Mayeux R; Smythe GA; Sachdev PS
    J Alzheimers Dis; 2011; 26(2):365-75. PubMed ID: 21709378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.